- Home
- CNTX vs DMA Comparison
CNTX vs DMA Comparison
Compare CNTX & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- DMA
- Stock Information
- Founded
- CNTX 2015
- DMA 2011
- Country
- CNTX United States
- DMA United States
- Employees
- CNTX N/A
- DMA N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- DMA Trusts Except Educational Religious and Charitable
- Sector
- CNTX Health Care
- DMA Finance
- Exchange
- CNTX Nasdaq
- DMA Nasdaq
- Market Cap
- CNTX 60.7M
- DMA 70.8M
- IPO Year
- CNTX 2021
- DMA N/A
- Fundamental
- Price
- CNTX $0.84
- DMA $8.03
- Analyst Decision
- CNTX Strong Buy
- DMA
- Analyst Count
- CNTX 5
- DMA 0
- Target Price
- CNTX $6.50
- DMA N/A
- AVG Volume (30 Days)
- CNTX 257.9K
- DMA 34.6K
- Earning Date
- CNTX 05-07-2025
- DMA 01-01-0001
- Dividend Yield
- CNTX N/A
- DMA 2.04%
- EPS Growth
- CNTX N/A
- DMA N/A
- EPS
- CNTX N/A
- DMA N/A
- Revenue
- CNTX N/A
- DMA N/A
- Revenue This Year
- CNTX N/A
- DMA N/A
- Revenue Next Year
- CNTX N/A
- DMA N/A
- P/E Ratio
- CNTX N/A
- DMA N/A
- Revenue Growth
- CNTX N/A
- DMA N/A
- 52 Week Low
- CNTX $0.55
- DMA $4.78
- 52 Week High
- CNTX $2.75
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- CNTX 56.99
- DMA 45.84
- Support Level
- CNTX $0.80
- DMA $7.66
- Resistance Level
- CNTX $0.89
- DMA $8.09
- Average True Range (ATR)
- CNTX 0.11
- DMA 0.31
- MACD
- CNTX 0.03
- DMA 0.01
- Stochastic Oscillator
- CNTX 73.80
- DMA 64.66
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.